Triopsy Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$250K
- Investors
-
3
Triopsy General Information
Description
Developer of 3D prostate biopsy technology designed for accurate cancer diagnosis. The company's technology uses an integrated pathology system for more precise specimen handling as well as for better tissue collection, enabling medical practitioners to diagnose and treat patients suspected of having prostate cancer.
Contact Information
Website
www.triopsy.com
Formerly Known As
3DBiopsy
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 12635 East Montview Boulevard
- Suite 100
- Aurora, CO 80045
- United States
+1 (800) 000-0000
Triopsy Timeline
Triopsy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 08-Jun-2022 | $250K | 00.000 | Completed | Generating Revenue | |
| 4. Angel (individual) | 28-Dec-2020 | 0000 | 00.000 | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 01-Sep-2020 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 19-Oct-2018 | $850K | $2.29M | Completed | Startup | |
| 1. Seed Round | 06-Jun-2017 | $1.44M | $1.44M | Completed | Startup |
Triopsy Patents
Triopsy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210068750-A1 | Three-dimensional biopsy imaging and planning system and method | Inactive | 09-Sep-2019 | 00000000000 | |
| US-10456119-B2 | Biopsy actuator assembly | Active | 10-Oct-2016 | 00000000000 | |
| US-20180098757-A1 | Biopsy actuator assembly | Active | 10-Oct-2016 | 00000000000 | |
| AU-2017344031-A1 | Biopsy actuator assembly | Inactive | 10-Oct-2016 | 00000000000 | |
| EP-3522793-A4 | Biopsy actuator assembly | Pending | 10-Oct-2016 | A61B10/0275 |
Triopsy Executive Team (6)
Triopsy Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brad Buscher | Triopsy | Chief Business Officer & Vice-Chair of the Board | 000 0000 |
| David Bostwick | Triopsy | Co-Chief Executive Officer & Board Member | 000 0000 |
| Deborah Wittman | Self | Chairwoman | 000 0000 |
| E. Crawford MD | Triopsy | Co-Founder, Chief Medical Advisor & Board Member | 000 0000 |
| James Lousararian JD | Self | Board Member | 000 0000 |
Triopsy Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Triopsy Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BioVentures Investors | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Clean Energy Venture Group | Angel Group | Minority | 000 0000 | 000000 0 | |
| Luminate NY Accelerator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |